New insights on mucormycosis and its association with the COVID-19 pandemic
COVID-19 continues to cause significant fatality worldwide. Glucocorticoids prove to play essential roles in COVID-19 management; however, the extensive use of steroids together with the virus immune dysregulation may increase the danger of secondary infections with mucormycosis, an angioinvasive fu...
Saved in:
| Main Authors: | Mona G Alshahawey, Ghadir S El-Housseiny, Noha S Elsayed, Mohammad Y Alshahrani, Lamia M EL Wakeel, Khaled M Aboshanab |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-02-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.future-science.com/doi/10.2144/fsoa-2021-0122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-COVID-19 Cutaneous Mucormycosis from a Plastic Surgical Perspective
by: Vimalendu Brajesh, et al.
Published: (2023-08-01) -
Cutaneous mucormycosis: Unveiling rare manifestations
by: Jyoti Jindal, et al.
Published: (2025-06-01) -
The Rising Threat of Mucormycosis: Oman’s Experience Before and During the COVID-19 Pandemic
by: Amina Al-Jardani, et al.
Published: (2024-11-01) -
COVID-19–associated central nervous system mucormycosis
by: Anjali Mishra, et al.
Published: (2021-01-01) -
COVID-19 associated mucormycosis: Staging and management recommendations (Report of a multi-disciplinary expert committee)
by: Hardeep Singh Malhotra, et al.
Published: (2021-10-01)